NCT00003816 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 199
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 15
- group Id
- BG005
- value
- 361
- units
- Participants
- groups
- description
- Patients receive busulfan IV over 2 hours every 6 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2. busulfan: Given IV cyclophosphamide: Given IV
- id
- BG000
- title
- BuCy
- description
- Patients receive cyclophosphamide IV over 2 hours on days -5 and -4 and total-body irradiation (TBI) twice daily on days -3 to -1. cyclophosphamide: Given IV total-body irradiation: Given twice daily for 3 days
- id
- BG001
- title
- CyTBI
- description
- Patients receive fludarabine IV over 30 minutes on days -6 to -2 and melphalan IV over 1 hour on days -3 and -2. fludarabine phosphate: Given IV melphalan: Given IV
- id
- BG002
- title
- FluMel
- description
- Patients receive etoposide IV over 26 hours beginning on day -5, cyclophosphamide IV over 2 hours on day -4, and TBI twice daily on days -3 to -1. cyclophosphamide: Given IV etoposide: Given IV total-body irradiation: Given twice daily for 3 days
- id
- BG003
- title
- VpCyTBI
- description
- Patients receive cyclophosphamide IV over 2 hours on days -5 to -2 and anti-thymocyte globulin IV over 4-8 hours on days -5 to -3. OR Patients receive cyclophosphamide IV over 24 hours, carboplatin IV over 24 hours, and thiotepa IV over 24 hours on days -7 to -4. OR Patients receive fludarabine IV over 30 minutes on days -5 to -1 and anti-thymocyte globulin IV over 4-8 hours on days -5 to -2. OR Patients receive cyclophosphamide IV over 2 hours on days -5 and -4, TBI twice daily on days -3 to -1, and anti-thymocyte globulin IV over 4-8 hours on days -3 to -1. OR Patients receive busulfan IV over 2 hours every 6 hours and anti-thymocyte globulin IV over 4-8 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2.
- id
- BG004
- title
- Other
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 6
- upper Limit
- 59
- value
- 46
- group Id
- BG001
- lower Limit
- 4
- upper Limit
- 50
- value
- 28
- group Id
- BG002
- lower Limit
- 6
- upper Limit
- 68
- value
- 48
- group Id
- BG003
- lower Limit
- 8
- upper Limit
- 55
- value
- 37
- group Id
- BG004
- lower Limit
- 6
- upper Limit
- 52
- value
- 41
- group Id
- BG005
- lower Limit
- 4
- upper Limit
- 68
- value
- 44
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 80
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 139
- title
- Female
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 119
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 222
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 53
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 188
- group Id
- BG003
- value
- 20
- group Id
- BG004
- value
- 12
- group Id
- BG005
- value
- 341
- title
- Non-Hispanic White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 12
- title
- Non-Hispanic African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- Non-Hispanic Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- Hispanic, White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- Non-Hispanic Native Am
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 199
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 15
- group Id
- BG005
- value
- 361
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 89
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 147
- title
- Acute myeloid leukemia
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 16
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 54
- title
- Acute lymphoblastic leukemia
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 37
- title
- Chronic myeloid or lymphocytic leukemia
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 56
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 72
- title
- Hodgkin or Non-Hodgkin lymphoma or multiple myeloma
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 43
- title
- Myelodysplastic syndrome or myeloproliferative disorder
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 7
- title
- Severe Aplastic anemia
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- title
- Solid Tumor
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Disease
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 73
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 161
- title
- Standard
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 126
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 200
- title
- High
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Risk group
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 199
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 15
- group Id
- BG005
- value
- 361
- units
- Participants
- groups
- description
- Patients receive busulfan IV over 2 hours every 6 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2. busulfan: Given IV cyclophosphamide: Given IV
- id
- BG000
- title
- BuCy
- description
- Patients receive cyclophosphamide IV over 2 hours on days -5 and -4 and total-body irradiation (TBI) twice daily on days -3 to -1. cyclophosphamide: Given IV total-body irradiation: Given twice daily for 3 days
- id
- BG001
- title
- CyTBI
- description
- Patients receive fludarabine IV over 30 minutes on days -6 to -2 and melphalan IV over 1 hour on days -3 and -2. fludarabine phosphate: Given IV melphalan: Given IV
- id
- BG002
- title
- FluMel
- description
- Patients receive etoposide IV over 26 hours beginning on day -5, cyclophosphamide IV over 2 hours on day -4, and TBI twice daily on days -3 to -1. cyclophosphamide: Given IV etoposide: Given IV total-body irradiation: Given twice daily for 3 days
- id
- BG003
- title
- VpCyTBI
- description
- Patients receive cyclophosphamide IV over 2 hours on days -5 to -2 and anti-thymocyte globulin IV over 4-8 hours on days -5 to -3. OR Patients receive cyclophosphamide IV over 24 hours, carboplatin IV over 24 hours, and thiotepa IV over 24 hours on days -7 to -4. OR Patients receive fludarabine IV over 30 minutes on days -5 to -1 and anti-thymocyte globulin IV over 4-8 hours on days -5 to -2. OR Patients receive cyclophosphamide IV over 2 hours on days -5 and -4, TBI twice daily on days -3 to -1, and anti-thymocyte globulin IV over 4-8 hours on days -3 to -1. OR Patients receive busulfan IV over 2 hours every 6 hours and anti-thymocyte globulin IV over 4-8 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2.
- id
- BG004
- title
- Other
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 6
- upper Limit
- 59
- value
- 46
- group Id
- BG001
- lower Limit
- 4
- upper Limit
- 50
- value
- 28
- group Id
- BG002
- lower Limit
- 6
- upper Limit
- 68
- value
- 48
- group Id
- BG003
- lower Limit
- 8
- upper Limit
- 55
- value
- 37
- group Id
- BG004
- lower Limit
- 6
- upper Limit
- 52
- value
- 41
- group Id
- BG005
- lower Limit
- 4
- upper Limit
- 68
- value
- 44
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 80
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 139
- title
- Female
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 119
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 222
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 53
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 188
- group Id
- BG003
- value
- 20
- group Id
- BG004
- value
- 12
- group Id
- BG005
- value
- 341
- title
- Non-Hispanic White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 12
- title
- Non-Hispanic African American
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- Non-Hispanic Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- title
- Hispanic, White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- title
- Non-Hispanic Native Am
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 199
- group Id
- BG003
- value
- 23
- group Id
- BG004
- value
- 15
- group Id
- BG005
- value
- 361
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 89
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 147
- title
- Acute myeloid leukemia
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 16
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 54
- title
- Acute lymphoblastic leukemia
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 37
- title
- Chronic myeloid or lymphocytic leukemia
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 56
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 72
- title
- Hodgkin or Non-Hodgkin lymphoma or multiple myeloma
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 43
- title
- Myelodysplastic syndrome or myeloproliferative disorder
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 7
- title
- Severe Aplastic anemia
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- title
- Solid Tumor
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Disease
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 73
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 161
- title
- Standard
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 126
- group Id
- BG003
- value
- 13
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 200
- title
- High
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Risk group
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle